Entero Healthcare Solutions Complete Financial Statements

In FY2025, Entero Healthcare Solutions (ENTERO) reported revenue ₹1,576 Cr, net profit ₹37 Cr and EPS ₹7.26, with a net profit margin of 2.3% and ROE of 2.1%. Full financial statements from FY2020 to FY2025 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see ENTERO stock overview.

6 Years of Data
2025 - 2020

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 2.35% 2025 data
EBITDA Margin 4.25% 2025 data
Operating Margin 4.00% 2025 data
Return on Assets 1.37% 2025 data
Return on Equity 2.09% 2025 data

Balance Sheet Ratios

Current Ratio 23.86 2025 data
Equity Ratio 65.48% 2025 data
Asset Turnover 0.58 2025 data

ENTERO Revenue, Net Profit & EBITDA — Year-on-Year Growth

ENTERO YoY (Sept 2024 vs Sept 2025) — revenue +20.1%, net profit +42.3%, EBITDA +24.1%, expenses +20.0%.

Revenue Growth
+20.1%
Year-over-Year
Net Profit Growth
+42.3%
Year-over-Year
EBITDA Growth
+24.1%
Year-over-Year
Expense Growth
+20.0%
Year-over-Year
Assets Growth
+15.3%
Year-over-Year
Equity Growth
+7.9%
Year-over-Year
Operating Cash Flow Growth
-108.1%
Year-over-Year
Investing Cash Flow Growth
+133.0%
Year-over-Year
Financing Cash Flow Growth
-108.6%
Year-over-Year

ENTERO Income Statement — Revenue, EBITDA & Net Profit

Entero Healthcare Solutions revenue ₹1,576 Cr, EBITDA ₹67 Cr, net profit ₹37 Cr, EPS ₹7.26 (2025) — net profit margin 2.3%. Explore ENTERO intrinsic value to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Dec 2022
Revenue 1,576 1,346 1,410 1,711 1,312 1,043 1,111 1,367 998 888 901 994 832
Expenses 1,509 1,290 1,354 1,647 1,258 1,005 1,067 1,309 968 867 873 964 810
EBITDA 67 56 56 64 54 38 44 58 31 21 27 30 21
Operating Profit Margin % 4.00% 4.00% 4.00% 3.00% 3.00% 3.00% 3.00% 4.00% 3.00% 2.00% 3.00% 3.00% 2.00%
Depreciation 10 9 9 10 8 7 7 8 6 7 6 6 5
Interest 12 11 11 14 12 17 10 10 18 13 14 16 13
Profit Before Tax 45 37 36 40 35 14 27 39 7 1 7 8 3
Tax 8 6 6 7 9 -8 7 10 2 5 0 1 -1
Net Profit 37 31 30 34 26 21 21 30 5 -4 6 7 4
Earnings Per Share (₹) 7.26 5.91 6.39 6.35 5.43 5.73 4.62 5.85 3.24 1.49 15.18 4.21 8.67

ENTERO Balance Sheet — Assets, Liabilities & Shareholders' Equity

ENTERO total assets ₹2,703 Cr, total equity ₹1,770 Cr, total liabilities ₹ Cr (2025) — ROE 2.1%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020
ASSETS
Total Assets 2,703 2,345 1,309 1,126 836 749
Current Assets 2,076 2,011 1,023 851 636 552
Fixed Assets 559 289 268 262 189 186
Capital Work in Progress 0 0 0 1 2 2
Investments 58 0 0 0 0 0
Other Assets 2,085 2,056 1,041 863 645 561
LIABILITIES
Total Liabilities
Current Liabilities 87 102 87 101 58 56
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 1,770 1,641 598 563 487 424
Share Capital 44 44 4 4 517 439
Reserves & Surplus 1,676 1,593 -73 -62 -32 -16

ENTERO Cash Flow Statement — Operating, Investing & Financing

Entero Healthcare Solutions operating cash flow ₹-77 Cr, investing ₹232 Cr, financing ₹-74 Cr, net cash flow ₹82 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Operating Activities -77 -37 -45 -35 -69 -37
Investing Activities 232 -704 -49 -162 -31 -203
Financing Activities -74 863 73 211 89 217
Net Cash Flow 82 122 -21 14 -11 -23